Differentiating symptomatic Parkin mutations carriers from patients with idiopathic Parkinson’s disease: Contribution of automated segmentation neuroimaging method
Abstract Background Parkin (PARK2) gene mutations are the predominant cause of autosomal recessive parkinsonism. Characteristic features include: early onset symptoms with slow clinical course, good response to low doses of levodopa, and frequently treatment-induced dyskinesia. Studies using a voxel...
Gespeichert in:
Veröffentlicht in: | Parkinsonism & related disorders 2012-06, Vol.18 (5), p.562-566 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 566 |
---|---|
container_issue | 5 |
container_start_page | 562 |
container_title | Parkinsonism & related disorders |
container_volume | 18 |
creator | Bilgic, Basar Bayram, Ali Arslan, Ali Bilgin Hanagasi, Hasmet Dursun, Burcu Gurvit, Hakan Emre, Murat Lohmann, Ebba |
description | Abstract Background Parkin (PARK2) gene mutations are the predominant cause of autosomal recessive parkinsonism. Characteristic features include: early onset symptoms with slow clinical course, good response to low doses of levodopa, and frequently treatment-induced dyskinesia. Studies using a voxel-based morphometry approach showed a decrease in the gray matter volume of the basal ganglia in mutation carriers during the symptomatic stages. A bilateral, presumably compensatory increase of basal ganglia gray matter value was recently demonstrated in asymptomatic Parkin mutation carriers. Behavioral disorders including: anxiety, psychosis, panic attacks, depression, disturbed sexual, behavioral and obsessive–compulsive disorders have been reported in these patients. Method A total of 28 Parkinson’s Disease (PD) patients consisting of 10 Young-Onset without Parkin mutations (YOPD), 9 Young-Onset with Parkin mutations (YOPD-p), 9 Late-Onset without Parkin mutations (LOPD) and 32 healthy control subjects were studied with an automated volumetric assessment method to quantify subcortical atrophy. Patients but not controls also underwent a neuropsychological and neuropsychiatric assessment. Results Results revealed a reduction of bilateral caudate nuclei volumes in YOPD-p patients compared to the YOPD patients while there were no statistically significant differences between other groups. YOPD-p patients showed similar results to other patient groups on neuropsychiatric and neuropsychological evaluation measures. Conclusion YOPD-p and YOPD patients showed a different pattern of volume changes in basal ganglia. Despite its relatively benign clinical course, carrying the Parkin mutation seems to be associated with greater atrophy in subcortical structures. Failure of compensatory mechanisms, different mutation types and pathophysiologic processes may underlie this diverse pattern of subcortical brain changes. |
doi_str_mv | 10.1016/j.parkreldis.2012.02.017 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1015244818</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S1353802012000752</els_id><sourcerecordid>1015244818</sourcerecordid><originalsourceid>FETCH-LOGICAL-c429t-eb931feafb3761366b4bc4ff25cafc99721d86cb901958b18735066d32c9c6d3</originalsourceid><addsrcrecordid>eNqNUtuKFDEQbURx19VfkDz6MmOSvvsg6HiFBQX3PaTTlZnMdidtKr0yb_6GH-CP-SVWz6wr-CQUVBLOqVM5VVnGBF8LLqrn-_Wk43WEoXe4llzINacQ9b3sXDR1viqFrO7TOS_zVcMlP8seIe4553XJ84fZmZRFUcqiPc9-vnHWQgSfnE7ObxkeximFkS6GfSYR59k4J7oGj8zoGB1EZDaGkU30SkRk31zaMde7QC-7Ox4G_-v7D2TUI2iEF2wTfIqum5daLFim56MQ9AxhO1KlowrzMMfgRr1d2hkh7UL_OHtg9YDw5DZfZFfv3l5tPqwuP73_uHl1uTKFbNMKujYXFrTt8roSeVV1RWcKa2VptDVtW0vRN5XpWi7asukWq0peVX0uTWsoXWTPTmWnGL7OgEmNDg0Mg_YQZlTkPblWNKIhaHOCmhgQI1g1Reo5Hgi04Cq1V39npJYZKU4haqI-vVWZuxH6O-KfoRDg9QkA9NUb8luhIaMN9C6CSaoP7n9UXv5TxAzOO6OHazgA7sMcPVmphEIiqC_LriyrIuRxTWT-Gxrfw9M</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1015244818</pqid></control><display><type>article</type><title>Differentiating symptomatic Parkin mutations carriers from patients with idiopathic Parkinson’s disease: Contribution of automated segmentation neuroimaging method</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Bilgic, Basar ; Bayram, Ali ; Arslan, Ali Bilgin ; Hanagasi, Hasmet ; Dursun, Burcu ; Gurvit, Hakan ; Emre, Murat ; Lohmann, Ebba</creator><creatorcontrib>Bilgic, Basar ; Bayram, Ali ; Arslan, Ali Bilgin ; Hanagasi, Hasmet ; Dursun, Burcu ; Gurvit, Hakan ; Emre, Murat ; Lohmann, Ebba</creatorcontrib><description>Abstract Background Parkin (PARK2) gene mutations are the predominant cause of autosomal recessive parkinsonism. Characteristic features include: early onset symptoms with slow clinical course, good response to low doses of levodopa, and frequently treatment-induced dyskinesia. Studies using a voxel-based morphometry approach showed a decrease in the gray matter volume of the basal ganglia in mutation carriers during the symptomatic stages. A bilateral, presumably compensatory increase of basal ganglia gray matter value was recently demonstrated in asymptomatic Parkin mutation carriers. Behavioral disorders including: anxiety, psychosis, panic attacks, depression, disturbed sexual, behavioral and obsessive–compulsive disorders have been reported in these patients. Method A total of 28 Parkinson’s Disease (PD) patients consisting of 10 Young-Onset without Parkin mutations (YOPD), 9 Young-Onset with Parkin mutations (YOPD-p), 9 Late-Onset without Parkin mutations (LOPD) and 32 healthy control subjects were studied with an automated volumetric assessment method to quantify subcortical atrophy. Patients but not controls also underwent a neuropsychological and neuropsychiatric assessment. Results Results revealed a reduction of bilateral caudate nuclei volumes in YOPD-p patients compared to the YOPD patients while there were no statistically significant differences between other groups. YOPD-p patients showed similar results to other patient groups on neuropsychiatric and neuropsychological evaluation measures. Conclusion YOPD-p and YOPD patients showed a different pattern of volume changes in basal ganglia. Despite its relatively benign clinical course, carrying the Parkin mutation seems to be associated with greater atrophy in subcortical structures. Failure of compensatory mechanisms, different mutation types and pathophysiologic processes may underlie this diverse pattern of subcortical brain changes.</description><identifier>ISSN: 1353-8020</identifier><identifier>EISSN: 1873-5126</identifier><identifier>DOI: 10.1016/j.parkreldis.2012.02.017</identifier><identifier>PMID: 22445249</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Adult ; Age of Onset ; Aged ; Analysis of Variance ; Automatic segmentation ; Basal Ganglia - pathology ; Brain Mapping ; Cognition Disorders - etiology ; Cognition Disorders - pathology ; Female ; Functional Laterality ; Humans ; Image Processing, Computer-Assisted ; Magnetic Resonance Imaging ; Male ; Middle Aged ; MRI ; Mutation - genetics ; Neurology ; Neuropsychological Tests ; Parkin gene ; Parkinson Disease - complications ; Parkinson Disease - genetics ; Parkinson Disease - pathology ; Parkinson’s disease ; Psychiatric Status Rating Scales ; Ubiquitin-Protein Ligases - genetics ; Young Adult</subject><ispartof>Parkinsonism & related disorders, 2012-06, Vol.18 (5), p.562-566</ispartof><rights>Elsevier Ltd</rights><rights>2012 Elsevier Ltd</rights><rights>Copyright © 2012 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c429t-eb931feafb3761366b4bc4ff25cafc99721d86cb901958b18735066d32c9c6d3</citedby><cites>FETCH-LOGICAL-c429t-eb931feafb3761366b4bc4ff25cafc99721d86cb901958b18735066d32c9c6d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.parkreldis.2012.02.017$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3548,27923,27924,45994</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22445249$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bilgic, Basar</creatorcontrib><creatorcontrib>Bayram, Ali</creatorcontrib><creatorcontrib>Arslan, Ali Bilgin</creatorcontrib><creatorcontrib>Hanagasi, Hasmet</creatorcontrib><creatorcontrib>Dursun, Burcu</creatorcontrib><creatorcontrib>Gurvit, Hakan</creatorcontrib><creatorcontrib>Emre, Murat</creatorcontrib><creatorcontrib>Lohmann, Ebba</creatorcontrib><title>Differentiating symptomatic Parkin mutations carriers from patients with idiopathic Parkinson’s disease: Contribution of automated segmentation neuroimaging method</title><title>Parkinsonism & related disorders</title><addtitle>Parkinsonism Relat Disord</addtitle><description>Abstract Background Parkin (PARK2) gene mutations are the predominant cause of autosomal recessive parkinsonism. Characteristic features include: early onset symptoms with slow clinical course, good response to low doses of levodopa, and frequently treatment-induced dyskinesia. Studies using a voxel-based morphometry approach showed a decrease in the gray matter volume of the basal ganglia in mutation carriers during the symptomatic stages. A bilateral, presumably compensatory increase of basal ganglia gray matter value was recently demonstrated in asymptomatic Parkin mutation carriers. Behavioral disorders including: anxiety, psychosis, panic attacks, depression, disturbed sexual, behavioral and obsessive–compulsive disorders have been reported in these patients. Method A total of 28 Parkinson’s Disease (PD) patients consisting of 10 Young-Onset without Parkin mutations (YOPD), 9 Young-Onset with Parkin mutations (YOPD-p), 9 Late-Onset without Parkin mutations (LOPD) and 32 healthy control subjects were studied with an automated volumetric assessment method to quantify subcortical atrophy. Patients but not controls also underwent a neuropsychological and neuropsychiatric assessment. Results Results revealed a reduction of bilateral caudate nuclei volumes in YOPD-p patients compared to the YOPD patients while there were no statistically significant differences between other groups. YOPD-p patients showed similar results to other patient groups on neuropsychiatric and neuropsychological evaluation measures. Conclusion YOPD-p and YOPD patients showed a different pattern of volume changes in basal ganglia. Despite its relatively benign clinical course, carrying the Parkin mutation seems to be associated with greater atrophy in subcortical structures. Failure of compensatory mechanisms, different mutation types and pathophysiologic processes may underlie this diverse pattern of subcortical brain changes.</description><subject>Adult</subject><subject>Age of Onset</subject><subject>Aged</subject><subject>Analysis of Variance</subject><subject>Automatic segmentation</subject><subject>Basal Ganglia - pathology</subject><subject>Brain Mapping</subject><subject>Cognition Disorders - etiology</subject><subject>Cognition Disorders - pathology</subject><subject>Female</subject><subject>Functional Laterality</subject><subject>Humans</subject><subject>Image Processing, Computer-Assisted</subject><subject>Magnetic Resonance Imaging</subject><subject>Male</subject><subject>Middle Aged</subject><subject>MRI</subject><subject>Mutation - genetics</subject><subject>Neurology</subject><subject>Neuropsychological Tests</subject><subject>Parkin gene</subject><subject>Parkinson Disease - complications</subject><subject>Parkinson Disease - genetics</subject><subject>Parkinson Disease - pathology</subject><subject>Parkinson’s disease</subject><subject>Psychiatric Status Rating Scales</subject><subject>Ubiquitin-Protein Ligases - genetics</subject><subject>Young Adult</subject><issn>1353-8020</issn><issn>1873-5126</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNUtuKFDEQbURx19VfkDz6MmOSvvsg6HiFBQX3PaTTlZnMdidtKr0yb_6GH-CP-SVWz6wr-CQUVBLOqVM5VVnGBF8LLqrn-_Wk43WEoXe4llzINacQ9b3sXDR1viqFrO7TOS_zVcMlP8seIe4553XJ84fZmZRFUcqiPc9-vnHWQgSfnE7ObxkeximFkS6GfSYR59k4J7oGj8zoGB1EZDaGkU30SkRk31zaMde7QC-7Ox4G_-v7D2TUI2iEF2wTfIqum5daLFim56MQ9AxhO1KlowrzMMfgRr1d2hkh7UL_OHtg9YDw5DZfZFfv3l5tPqwuP73_uHl1uTKFbNMKujYXFrTt8roSeVV1RWcKa2VptDVtW0vRN5XpWi7asukWq0peVX0uTWsoXWTPTmWnGL7OgEmNDg0Mg_YQZlTkPblWNKIhaHOCmhgQI1g1Reo5Hgi04Cq1V39npJYZKU4haqI-vVWZuxH6O-KfoRDg9QkA9NUb8luhIaMN9C6CSaoP7n9UXv5TxAzOO6OHazgA7sMcPVmphEIiqC_LriyrIuRxTWT-Gxrfw9M</recordid><startdate>20120601</startdate><enddate>20120601</enddate><creator>Bilgic, Basar</creator><creator>Bayram, Ali</creator><creator>Arslan, Ali Bilgin</creator><creator>Hanagasi, Hasmet</creator><creator>Dursun, Burcu</creator><creator>Gurvit, Hakan</creator><creator>Emre, Murat</creator><creator>Lohmann, Ebba</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20120601</creationdate><title>Differentiating symptomatic Parkin mutations carriers from patients with idiopathic Parkinson’s disease: Contribution of automated segmentation neuroimaging method</title><author>Bilgic, Basar ; Bayram, Ali ; Arslan, Ali Bilgin ; Hanagasi, Hasmet ; Dursun, Burcu ; Gurvit, Hakan ; Emre, Murat ; Lohmann, Ebba</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c429t-eb931feafb3761366b4bc4ff25cafc99721d86cb901958b18735066d32c9c6d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Adult</topic><topic>Age of Onset</topic><topic>Aged</topic><topic>Analysis of Variance</topic><topic>Automatic segmentation</topic><topic>Basal Ganglia - pathology</topic><topic>Brain Mapping</topic><topic>Cognition Disorders - etiology</topic><topic>Cognition Disorders - pathology</topic><topic>Female</topic><topic>Functional Laterality</topic><topic>Humans</topic><topic>Image Processing, Computer-Assisted</topic><topic>Magnetic Resonance Imaging</topic><topic>Male</topic><topic>Middle Aged</topic><topic>MRI</topic><topic>Mutation - genetics</topic><topic>Neurology</topic><topic>Neuropsychological Tests</topic><topic>Parkin gene</topic><topic>Parkinson Disease - complications</topic><topic>Parkinson Disease - genetics</topic><topic>Parkinson Disease - pathology</topic><topic>Parkinson’s disease</topic><topic>Psychiatric Status Rating Scales</topic><topic>Ubiquitin-Protein Ligases - genetics</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bilgic, Basar</creatorcontrib><creatorcontrib>Bayram, Ali</creatorcontrib><creatorcontrib>Arslan, Ali Bilgin</creatorcontrib><creatorcontrib>Hanagasi, Hasmet</creatorcontrib><creatorcontrib>Dursun, Burcu</creatorcontrib><creatorcontrib>Gurvit, Hakan</creatorcontrib><creatorcontrib>Emre, Murat</creatorcontrib><creatorcontrib>Lohmann, Ebba</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Parkinsonism & related disorders</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bilgic, Basar</au><au>Bayram, Ali</au><au>Arslan, Ali Bilgin</au><au>Hanagasi, Hasmet</au><au>Dursun, Burcu</au><au>Gurvit, Hakan</au><au>Emre, Murat</au><au>Lohmann, Ebba</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Differentiating symptomatic Parkin mutations carriers from patients with idiopathic Parkinson’s disease: Contribution of automated segmentation neuroimaging method</atitle><jtitle>Parkinsonism & related disorders</jtitle><addtitle>Parkinsonism Relat Disord</addtitle><date>2012-06-01</date><risdate>2012</risdate><volume>18</volume><issue>5</issue><spage>562</spage><epage>566</epage><pages>562-566</pages><issn>1353-8020</issn><eissn>1873-5126</eissn><abstract>Abstract Background Parkin (PARK2) gene mutations are the predominant cause of autosomal recessive parkinsonism. Characteristic features include: early onset symptoms with slow clinical course, good response to low doses of levodopa, and frequently treatment-induced dyskinesia. Studies using a voxel-based morphometry approach showed a decrease in the gray matter volume of the basal ganglia in mutation carriers during the symptomatic stages. A bilateral, presumably compensatory increase of basal ganglia gray matter value was recently demonstrated in asymptomatic Parkin mutation carriers. Behavioral disorders including: anxiety, psychosis, panic attacks, depression, disturbed sexual, behavioral and obsessive–compulsive disorders have been reported in these patients. Method A total of 28 Parkinson’s Disease (PD) patients consisting of 10 Young-Onset without Parkin mutations (YOPD), 9 Young-Onset with Parkin mutations (YOPD-p), 9 Late-Onset without Parkin mutations (LOPD) and 32 healthy control subjects were studied with an automated volumetric assessment method to quantify subcortical atrophy. Patients but not controls also underwent a neuropsychological and neuropsychiatric assessment. Results Results revealed a reduction of bilateral caudate nuclei volumes in YOPD-p patients compared to the YOPD patients while there were no statistically significant differences between other groups. YOPD-p patients showed similar results to other patient groups on neuropsychiatric and neuropsychological evaluation measures. Conclusion YOPD-p and YOPD patients showed a different pattern of volume changes in basal ganglia. Despite its relatively benign clinical course, carrying the Parkin mutation seems to be associated with greater atrophy in subcortical structures. Failure of compensatory mechanisms, different mutation types and pathophysiologic processes may underlie this diverse pattern of subcortical brain changes.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>22445249</pmid><doi>10.1016/j.parkreldis.2012.02.017</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1353-8020 |
ispartof | Parkinsonism & related disorders, 2012-06, Vol.18 (5), p.562-566 |
issn | 1353-8020 1873-5126 |
language | eng |
recordid | cdi_proquest_miscellaneous_1015244818 |
source | MEDLINE; ScienceDirect Journals (5 years ago - present) |
subjects | Adult Age of Onset Aged Analysis of Variance Automatic segmentation Basal Ganglia - pathology Brain Mapping Cognition Disorders - etiology Cognition Disorders - pathology Female Functional Laterality Humans Image Processing, Computer-Assisted Magnetic Resonance Imaging Male Middle Aged MRI Mutation - genetics Neurology Neuropsychological Tests Parkin gene Parkinson Disease - complications Parkinson Disease - genetics Parkinson Disease - pathology Parkinson’s disease Psychiatric Status Rating Scales Ubiquitin-Protein Ligases - genetics Young Adult |
title | Differentiating symptomatic Parkin mutations carriers from patients with idiopathic Parkinson’s disease: Contribution of automated segmentation neuroimaging method |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T20%3A36%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Differentiating%20symptomatic%20Parkin%20mutations%20carriers%20from%20patients%20with%20idiopathic%20Parkinson%E2%80%99s%20disease:%20Contribution%20of%20automated%20segmentation%20neuroimaging%20method&rft.jtitle=Parkinsonism%20&%20related%20disorders&rft.au=Bilgic,%20Basar&rft.date=2012-06-01&rft.volume=18&rft.issue=5&rft.spage=562&rft.epage=566&rft.pages=562-566&rft.issn=1353-8020&rft.eissn=1873-5126&rft_id=info:doi/10.1016/j.parkreldis.2012.02.017&rft_dat=%3Cproquest_cross%3E1015244818%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1015244818&rft_id=info:pmid/22445249&rft_els_id=1_s2_0_S1353802012000752&rfr_iscdi=true |